Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 68788-4096

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68788-4096). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atorvastatin Calcium Tab Usp 20mg (Atorvastatin 20mg 1000s Container Label)

Atorvastatin Calcium Tab Usp 20mg (Atorvastatin 20mg 1000s Container Label)
Label for Atorvastatin Calcium Tablets USP 20 mg film-coated tablets by Preferred Pharmaceuticals Inc. The label includes dosage instructions in English and Spanish, storage warnings, dosage strength, and manufacturer details (MSN Laboratories Pvt. Ltd.). It also features barcode and QR code identifiers, with a caution against transfer of the drug to others.*
FDA Label Image

Atorvastatin-figure-01 (Atorvastatin Figure 01)

Atorvastatin-figure-01 (Atorvastatin Figure 01)
A cumulative incidence line graph comparing Atorvastatin with placebo over approximately 3.5 years. The solid line represents Atorvastatin, showing a lower cumulative incidence percentage than the dashed line for placebo, with hazard ratio and p-value indicated on the chart.*
FDA Label Image

Atorvastatin-figure-02 (Atorvastatin Figure 02)

Atorvastatin-figure-02 (Atorvastatin Figure 02)
A line graph showing cumulative hazard percentage over time to first primary endpoint through four years of follow-up. It compares Atorvastatin (solid line) against Placebo (dashed line), indicating a lower cumulative hazard for Atorvastatin across the timeframe. The graph includes a hazard ratio (HR) of 0.63 with a confidence interval of 0.48 to 0.83 and a p-value of 0.001.*
FDA Label Image

Atorvastatin-figure-03 (Atorvastatin Figure 03)

Atorvastatin-figure-03 (Atorvastatin Figure 03)
A line graph comparing the percentage of subjects experiencing an event over five years for Atorvastatin 10 mg and 80 mg dosages. The x-axis represents time to first major cardiovascular endpoint in years, and the y-axis shows the percentage of subjects. The 80 mg dosage has a lower event rate compared to the 10 mg dosage, with a hazard ratio of 0.78 (0.69-0.89) and P=0.0002.*
FDA Label Image

Structure (Atorvastatin Structure)

Structure (Atorvastatin Structure)
Chemical structure of atorvastatin calcium showing the molecular composition and arrangement, including the calcium ion complex and associated water molecules (3H2O). The diagram depicts the arrangement of rings and functional groups characteristic of atorvastatin calcium.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.